Literature DB >> 18398434

Influence of the cystathionine beta-synthase 844ins68 and methylenetetrahydrofolate reductase 677C>T polymorphisms on folate and homocysteine concentrations.

Carolyn M Summers1, Andrea L Hammons, Laura E Mitchell, Jayne V Woodside, John W G Yarnell, Ian S Young, Alun Evans, Alexander S Whitehead.   

Abstract

A high homocysteine, low folate phenotype is a feature of many diseases. The effect of the cystathionine beta-synthase (CBS) 844ins68 polymorphism on homocysteine and folate concentrations was examined alone and in the context of the 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism in a Northwestern European male population. The MTHFR 677TT genotype is known to be associated with increased homocysteine and decreased folate relative to CT heterozygotes and CC homozygotes in this and other populations. MTHFR 677TT homozygotes who were also CBS 844ins68 carriers had homocysteine and folate concentrations similar to those of individuals with the MTHFR 677CT and CC genotypes. Homocysteine levels in MTHFR 677TT subjects carrying the CBS 844ins68 allele were 24.1% lower than in non-carriers (6.66 vs 8.77 micromol/l, P=0.045), and serum folate levels were 27.7% higher (11.16 vs 8.74 nmol/l, P=0.034). These findings suggest that the CBS 844ins68 allele 'normalizes' homocysteine and folate levels in MTHFR 677TT individuals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18398434      PMCID: PMC4051220          DOI: 10.1038/ejhg.2008.69

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  23 in total

Review 1.  Biological and environmental determinants of plasma homocysteine.

Authors:  J Schneede; H Refsum; P M Ueland
Journal:  Semin Thromb Hemost       Date:  2000       Impact factor: 4.180

2.  Polygenic influence on plasma homocysteine: association of two prevalent mutations, the 844ins68 of cystathionine beta-synthase and A(2756)G of methionine synthase, with lowered plasma homocysteine levels.

Authors:  M Y Tsai; M Bignell; F Yang; B G Welge; K J Graham; N Q Hanson
Journal:  Atherosclerosis       Date:  2000-03       Impact factor: 5.162

3.  Gene-environment and gene-gene interaction in the determination of plasma homocysteine levels in healthy middle-aged men.

Authors:  V Dekou; V Gudnason; E Hawe; G J Miller; D Stansbie; S E Humphries
Journal:  Thromb Haemost       Date:  2001-01       Impact factor: 5.249

Review 4.  Folate, homocysteine and neural tube defects: an overview.

Authors:  N M van der Put; H W van Straaten; F J Trijbels; H J Blom
Journal:  Exp Biol Med (Maywood)       Date:  2001-04

5.  Influence of 699C-->T and 1080C-->T polymorphisms of the cystathionine beta-synthase gene on plasma homocysteine levels.

Authors:  O Aras; N Q Hanson; F Yang; M Y Tsai
Journal:  Clin Genet       Date:  2000-12       Impact factor: 4.438

6.  Large-scale population-based metabolic phenotyping of thirteen genetic polymorphisms related to one-carbon metabolism.

Authors:  Ase Fredriksen; Klaus Meyer; Per Magne Ueland; Stein Emil Vollset; Tom Grotmol; Jørn Schneede
Journal:  Hum Mutat       Date:  2007-09       Impact factor: 4.878

Review 7.  Biological and clinical implications of the MTHFR C677T polymorphism.

Authors:  P M Ueland; S Hustad; J Schneede; H Refsum; S E Vollset
Journal:  Trends Pharmacol Sci       Date:  2001-04       Impact factor: 14.819

8.  Genetic and nutritional factors contributing to hyperhomocysteinemia in young adults.

Authors:  Leo A J Kluijtmans; Ian S Young; Colin A Boreham; Liam Murray; Dorothy McMaster; Helene McNulty; J J Strain; Joseph McPartlin; John M Scott; Alexander S Whitehead
Journal:  Blood       Date:  2003-04-01       Impact factor: 22.113

9.  Genetic variants of homocysteine metabolizing enzymes and the risk of coronary artery disease.

Authors:  Bohumila Janosíková; Markéta Pavlíková; Dora Kocmanová; Andrea Vítová; Kamila Veselá; Lucie Krupková; Regina Kahleová; Jakub Krijt; Pavel Kraml; Josef Hyánek; Jana Zvárová; Michal Andel; Viktor Kozich
Journal:  Mol Genet Metab       Date:  2003-07       Impact factor: 4.797

10.  The molecular basis of homocystinuria due to cystathionine beta-synthase deficiency in Italian families, and report of four novel mutations.

Authors:  G Sebastio; M P Sperandeo; M Panico; R de Franchis; J P Kraus; G Andria
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

View more
  5 in total

1.  Characterisation of a human liver cystathionine beta synthase mRNA sequence corresponding to the c.[833T>C;844_845ins68] mutation in CBS gene.

Authors:  Jean-François Chassé; Robert Barouki
Journal:  Mol Cell Biochem       Date:  2009-07-11       Impact factor: 3.396

2.  Gene-gene interactions in the folate metabolic pathway and the risk of conotruncal heart defects.

Authors:  Philip J Lupo; Elizabeth Goldmuntz; Laura E Mitchell
Journal:  J Biomed Biotechnol       Date:  2010-01-12

3.  Genetic and biochemical determinants of serum concentrations of monocyte chemoattractant protein-1, a potential neural tube defect risk factor.

Authors:  Zhi-Yong Lu; Megan Morales; Stephanie Khartulyari; Minghua Mei; Kristen M Murphy; Anna Stanislawska-Sachadyn; Carolyn M Summers; Yuehua Huang; Joan M Von Feldt; Ian A Blair; Laura E Mitchell; Alexander S Whitehead
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2008-10

4.  The association between CBS 844ins68 polymorphism and head and neck squamous cell carcinoma risk - a case-control analysis.

Authors:  Ana L S Galbiatti; Mariangela T Ruiz; Luis S Raposo; José V Maniglia; Erika C Pavarino-Bertelli; Eny M Goloni-Bertollo
Journal:  Arch Med Sci       Date:  2010-10-26       Impact factor: 3.318

5.  The association between the 844ins68 polymorphism in the CBS gene and breast cancer.

Authors:  Martha Patricia Gallegos-Arreola; Luis Eduardo Figuera-Villanueva; Adriana Ramos-Silva; Efraín Salas-González; Ana María Puebla-Pérez; Valeria Peralta-Leal; José Elías García-Ortiz; Ingrid Patricia Dávalos-Rodríguez; Guillermo Moisés Zúñiga-González
Journal:  Arch Med Sci       Date:  2014-12-22       Impact factor: 3.318

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.